Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AyuFlex is a standardized aqueous extract derived from the edible fruits of *Terminalia chebula*. It is positioned as a dietary supplement for joint health, specifically targeting joint mobility, comfort, and functional capacity. Clinical studies in healthy overweight individuals have demonstrated its potential to improve knee joint discomfort during activity and overall whole-body joint function. The extract is characterized by its antioxidant and anti-inflammatory properties, which are attributed to its bioactive constituents, including tannins such as chebulinic acid and chebulagic acid. It is often marketed as an organic, non-GMO alternative for managing joint soreness and stiffness associated with exercise.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AyuFlex.